Vifor Pharma, OPKO Health ink licensing pact to develop Rayaldee to treat secondary hyperparathyroidism
Posted on10 May 2016
Tagsopko health, Rayaldee, secondary hyperparathyroidism, Vifor Fresenius Medical Care Renal Pharma, Vifor Pharma
Comments0
Vifor Fresenius Medical Care Renal Pharma (VFMCRP), a common company of Galenica and Fresenius Medical Care, and OPKO Health, have entered into... Read More